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Homogeneity of Kerato-Epithelin Codon 124
Mutations in Japanese Patients with Either of Two
Types of Corneal Stromal Dystrophy
To the Editor:
Granular corneal dystrophy Groenouw type 1 (CDGG1;
OMIM 121900 [http://www3.ncbi.nlm.nih.gov:80/
htbin-post/Omim/dispmim?121900]) is an autosomal
dominant form of corneal dystrophy that is character-
ized by discrete deposits of gray-white material in the
subepithelial and stromal layers of the cornea (Mannis
et al. 1997). The precise nature and source of these de-
posits are unclear. Amyloid deposits have been detected
in the corneas of older individuals with typical CDGG1
(Garner 1969; Akiya and Brown 1970). Lattice corneal
dystrophy type 1 (CDL1; OMIM 122200 [http://
www3.ncbi.nlm.nih.gov:80/htbin-post/Omim/dispmim?
122200]), which is clinically distinct from CDGG1, is
characterized by linear amyloid deposits in the subepi-
thelial and stromal layers of the cornea (Mannis et al.
1997). However, granular-lattice corneal dystrophy re-
cently has been described as having the clinical and his-
tological features of both granular and lattice corneal
dystrophies (Folberg et al. 1988, 1994; Holland et al.
1992; Rosenwasser et al. 1993). This condition has been
named “Avellino corneal dystrophy” (“ACD”; OMIM
121900 [http://www3.ncbi.nlm.nih.gov:80/htbin-post/
Omim/dispmim?121900]), because most of the affected
individuals could trace their origin to the Italian province
of Avellino (Holland et al. 1992).
Recently, four corneal disorders with autosomal dom-
inant traits, CDGG1, CDL1, ACD, and Reis-Bu¨cklers
corneal dystrophy (CDRB; OMIM 121900 [http://
www3.ncbi.nlm.nih.gov:80/htbin-post/Omim/dispmim?
121900]), have been mapped to chromosome 5q31
(Stone et al. 1994; Gregory et al. 1995; Korvatska et al.
1996; Small et al. 1996). More recently, these four cor-
neal dystrophies have all been shown to result from mu-
tations in the kerato-epithelin gene (Munier et al. 1997).
The mutations detected in Caucasian patients in Europe
were R124C, in two families with CDL1; R124H, in
two families with ACD; R555W, in one family with
CDGG1; and R555Q, in one family with CDRB. Each
of these four mutations affects the CpG dinucleotide of
an arginine codon. Kerato-epithelin genes with R124
mutations may form amyloidogenic intermediates that
precipitate in the cornea.
We have demonstrated the deposition of amyloid, a
feature of ACD, in corneal specimens from six of eight
Japanese patients with a clinical diagnosis of CDGG1
(Konishi et al. 1997). To investigate whether the high
frequency of amyloid deposition in Japanese patients
with CDGG1 is attributable to a specific mutation in
the kerato-epithelin gene or to other conditions, such as
aging, we screened kerato-epithelin genes from Japanese
patients with CDGG1, ACD, or CDL1 (primary corneal
amyloidosis).
The study subjects comprised 6 Japanese patients with
ACD (of whom 1, with recurrent disease, was the off-
spring from a consanguineous marriage), diagnosed by
histological examination; 10 patients with a clinical di-
agnosis of CDGG1 (of whom 2, with recurrent disease,
were the offspring from consanguineous marriages); and
6 patients with CDL1. None of the patients were related.
The mean age (SD) of the 6 patients with ACD was
70.5 (14.2) years, at the time of surgery, and that of
the 10 patients with CDGG1 was 50.1 (18.0) years,
at the time of their first visit to us. Individual exons
(exons 4–16) of the kerato-epithelin gene were amplified
from genomic DNA from each subject, by PCR with
primers described elsewhere (Munier et al. 1997), and
the amplification products were sequenced on both
strands. We detected a homozygous R124H
(np418GrA) mutation in the one ACD and two
CDGG1 patients with consanguineous parents and a
heterozygous R124H (np418GrA) mutation in the re-
maining five ACD and eight CDGG1 patients (fig. 1,
top). Patients with the homozygous mutation experi-
enced rapid progression of clinical manifestation and
visual deterioration at an early age and required kera-
toplasty in the 1st decade of life. These severe corneal
conditions resembled a variant of superficial granular
corneal dystrophy (Haddad et al. 1977; Owend et al.
1992; Sajjadi and Javadi 1992). A heterozygous R124C
(np417CrT) mutation was identified in the six patients
with CDL1 (fig. 1, bottom). To exclude the possibility
of contamination with mutated DNA in PCR or se-
quence-reaction mixtures, we also analyzed DNA from
control subjects, at the same time as our analysis of
patient DNA, and obtained normal nucleotide sequences
from the controls. We also screened 40 Japanese subjects
without corneal dystrophy and failed to detect any of
the mutations identified in the patients.
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Figure 1 Direct-sequencing analysis of kerato-epithelin gene of
patients with ACD (top; heterozygous GrA mutation at codon 124)
and CDL1 (bottom; heterozygous CrT mutation at codon 124). The
top line shows the normal DNA sequence.
Our results suggested two interesting genetic phenom-
ena in corneal stromal dystrophy in Japanese patients.
First, the R124H (np418GrA) mutation was identified
in 16 unrelated Japanese individuals with a clinical di-
agnosis of CDGG1 or a histological diagnosis of ACD.
The term “ACD” was proposed relatively recently (Hol-
land et al. 1992); ACD is a variant of CDGG1. Histo-
logical examination is required for diagnosis. In the pres-
ent study, individuals were diagnosed as having ACD on
the basis of histological examination. The earliest clinical
feature of ACD is the appearance of discrete granular
deposits, which is typical of CDGG1, and is followed
by the appearance of the lattice lesions. The youngest
patient identified by Holland et al. (1992) as showing
evidence of three typical lesions of ACD was 50 years
old. Thus, individuals !50 years old with ACD may be
misdiagnosed with CDGG1. The mean age of the 10
patients with a clinical diagnosis of CDGG1 at the time
of their first visit to us was 50.1 (18.0) years. The
responsible mutation in most Japanese patients with a
clinical diagnosis of CDGG1 may be R124H, which is
the same mutation as that associated only with the ACD
reported by Munier et al. (1997). This observation may
explain the high frequency of amyloid deposition, a fea-
ture of ACD, in corneal specimens of Japanese patients
with a clinical diagnosis of CDGG1 (Konishi et al.
1997). As mentioned above, patients with clinically typ-
ical CDGG1 are often found to have amyloid deposits,
on the basis of histological examination (Garner 1969;
Akiya and Brown 1970; Folberg et al. 1994). Indeed, in
addition to discrete gray-white opacities typical of
CDGG1, in the subepithelial stroma, several of the older
patients with a clinical diagnosis of CDGG1, in the pres-
ent study, showed a few whitish fusiform, stellate, or
spicular opacities, suggestive of amyloid deposits, in the
midstroma (Holland et al. 1992; Rosenwasser et al.
1993). Thus, clinical diagnosis of the different types of
corneal stromal dystrophy is difficult, especially for
CDGG1 and ACD. Direct corneal examination is not
sufficient to establish a diagnosis; histological exami-
nation or molecular characterization of the mutation is
required. The presence of the R124H mutation indicates
that, in the present study, the individuals diagnosed with
CDGG1 actually have ACD. The corneal appearance of
the CDGG1 patient carrying a R555W mutation, de-
scribed by Munier et al. (1997), differs from that of our
16 patients with the R124H mutation.
Second, our results demonstrate the homogeneity of
the R124H and R124Cmutations in the kerato-epithelin
gene, in Japanese patients with ACD and CDL1, re-
spectively. Another example of genetic homogeneity in
Japanese patients is provided by Oguchi disease (Fuchs
et al. 1995), a rare autosomal recessive form of congen-
ital stationary night blindness. Most patients described
as having Oguchi disease are from Japan. In Japan, five
of six patients with Oguchi disease have showed ho-
mozygous deletion of nucleotide position 1147
(1147delA) in codon 309 of the arrestin gene, and this
homogeneity has been suggested to be due to a single
founder mutation (Fuchs et al. 1995). In contrast, ho-
mogeneity of the R124 mutations of the kerato-epithelin
gene in Japanese patients with autosomal dominant
types of corneal dystrophy might not be due to single
founder mutations. The two mutations, R124H and
R124C, detected in the present study also are present in
European Caucasian patients with corneal dystrophies,
despite different ethnic groups (Munier et al. 1997), and
the R124-mutated kerato-epithelin gene certainly could
be associated with amyloidogenic intermediates that pre-
cipitate in the cornea.
These results suggest the possibility that the unique
mutations at codon 124 (R124H and R124C) in the
kerato-epithelin gene may be responsible for ACD and
CDL1, respectively. In this case, these R124 mutations
probably occur independently in the Japanese popula-
tion, similar to the nucleotide 11778 mutation of
mtDNA in Leber’s hereditary optic neuropathy (Brown
et al. 1995; Howell et al. 1995). Haplotype analysis of
the kerato-epithelin gene in individuals with ACD or
CDL1 should clarify this issue. Further nationwide stud-
ies will be necessary to confirm the genetic uniqueness
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of the kerato-epithelin mutation in individuals with these
two corneal dystrophies.
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Identification of an Interstitial Deletion in an Adult
Female with Schizophrenia, Mental Retardation, and
Dysmorphic Features: Further Support for a Putative
Schizophrenia-Susceptibility Locus at 5q21-23.1
To the Editor:
Schizophrenia is a common and complex mental dis-
order. Family, twin, and adoption studies provide over-
whelming but indirect evidence for a significant genetic
contribution to the etiology of schizophrenia (Gottes-
man 1967, 1982, 1991; Murray et al. 1986; Kendler
and Diehl 1993; Kendler et al. 1993). Cumulative evi-
dence from genetic linkage studies is now available to
suggest that schizophrenia-susceptibility genes may be
found in relatively broad regions on chromosomes 22q,
8p, and 6p (Schizophrenia Collaborative Linkage Group
1996a, 1996b).
Evidence suggesting linkage at the 5q21-31 locus has
also been provided independently by two groups
(Schwab et al. 1997; Straub et al. 1997), and the im-
plicated region consists of two partially overlapping
regions, which extend to a combined distance of 30–40
cM, with the strongest evidence for linkage, under the
